Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat.: Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release

被引:35
作者
de la Mora, Miguel Perez [1 ]
Hernandez-Gomez, Ana Maria [1 ]
Arizmendi-Garcia, Yexel [1 ]
Jacobsen, Kirsten X. [2 ]
Lara-Garcia, Daniel [1 ]
Flores-Gracia, Candy [1 ]
Crespo-Ramirez, Minerva [1 ]
Gallegos-Cari, Andrea [1 ]
Nuche-Bricaire, Avril [1 ]
Fuxe, Kiell [3 ]
机构
[1] Univ Nacl Autonoma Mexico, Inst Fisiol Celular, Dept Biophys, Mexico City 04510, DF, Mexico
[2] Univ Ottawa, Neurosci Res Inst, Dept Cellular & Mol Med, Ottawa, ON K1H 8M5, Canada
[3] Karolinska Inst, Dept Neurosci, Stockholm 17177, Sweden
关键词
amygdala; basolateral amygdaloid nucleus; glutamate; intercalated islands;
D O I
10.1111/j.1460-9568.2007.05963.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The amygdala plays a key role in fear and anxiety. The intercalated islands are clusters of glutamate-responsive GABAergic neurons rich in cholecystokinin (CCK)-2 receptors which control the trafficking of nerve impulses from the cerebral cortex to the central nucleus of amygdala. In this study, the nature of the CCK-glutamate-GABA interactions within the rat rostral amygdala, and their relevance for anxiety, were studied. CCK/gastrin-like immunoreactive nerve terminals were found to be mainly restricted to the paracapsular intercalated islands and the rostrolateral part of the main intercalated island. Behaviourally, the bilateral microinjection of CCK-4 (0.043-4.3 pmol/side) or CCK-8S (4.3 pmol/side) into the rostrolateral amygdala reduced the open-arm exploration in the elevated plus-maze without affecting locomotion. In contrast, neither CCK-4 nor CCK-8S (0.043-4.3 pmol/side) had any effects in the shock-probe burying test as compared with their saline-treated controls. Biochemically, CCK-4 (0.3 and 1.5 mu M), unlike CCK-8S, enhanced significantly the K+-stimulated release of [H-3]GABA from amygdala slices. These effects were fully prevented by prior superfusion of the slices with either the selective CCK-2 receptor antagonist CR2945 (3 mu M), or 6,7-dinitroquinoxaline-2,3(1H,4H)-dione (DNQX), 10 mu M, a glutamatergic (+/-)-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA)/kainate receptor antagonist. It is suggested that CCK modulates glutamate-GABA mechanisms by acting on CCK-2 receptors via volume transmission occurring at the level of the basolateral amygdaloid nucleus and/or by synaptic or perisynaptic volume transmission in the region of the rostrolateral main and paracapsular intercalated islands, resulting in subsequent disinhibition of the central amygdaloid nucleus and anxiety or panic-like behaviour.
引用
收藏
页码:3614 / 3630
页数:17
相关论文
共 96 条
  • [1] Existence and theoretical aspects of homomeric and heteromeric dopamine receptor complexes and their relevance for neurological diseases
    Agnati, LF
    Ferre, S
    Burioni, R
    Woods, A
    Genedani, S
    Franco, R
    Fuxe, K
    [J]. NEUROMOLECULAR MEDICINE, 2005, 7 (1-2) : 61 - 78
  • [2] A CORRELATION-ANALYSIS OF THE REGIONAL DISTRIBUTION OF CENTRAL ENKEPHALIN AND BETA-ENDORPHIN IMMUNOREACTIVE TERMINALS AND OF OPIATE RECEPTORS IN ADULT AND OLD MALE-RATS - EVIDENCE FOR THE EXISTENCE OF 2 MAIN TYPES OF COMMUNICATION IN THE CENTRAL-NERVOUS-SYSTEM - THE VOLUME TRANSMISSION AND THE WIRING TRANSMISSIOI
    AGNATI, LF
    FUXE, K
    ZOLI, M
    OZINI, I
    TOFFANO, G
    FERRAGUTI, F
    [J]. ACTA PHYSIOLOGICA SCANDINAVICA, 1986, 128 (02): : 201 - 207
  • [3] [Anonymous], 1991, Volume Transmission in the Brain: Novel Mechanisms for Neural Transmission
  • [4] Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats
    Basso, AM
    Spina, M
    Rivier, J
    Vale, W
    Koob, GF
    [J]. PSYCHOPHARMACOLOGY, 1999, 145 (01) : 21 - 30
  • [5] ANTIPANIC DRUG TREATMENTS - FAILURE TO EXHIBIT ANXIOLYTIC-LIKE EFFECTS ON DEFENSIVE BURYING BEHAVIOR
    BEARDSLEE, SL
    PAPADAKIS, E
    FONTANA, DJ
    COMMISSARIS, RL
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1990, 35 (02) : 451 - 455
  • [6] Beinfeld Margery C., 1995, P585
  • [7] ASYMMETRY IN BEHAVIORAL-RESPONSES TO CHOLECYSTOKININ MICROINJECTED INTO RAT NUCLEUS-ACCUMBENS AND AMYGDALA
    BELCHEVA, I
    BELCHEVA, S
    PETKOV, VV
    PETKOV, VD
    [J]. NEUROPHARMACOLOGY, 1994, 33 (08) : 995 - 1002
  • [8] GABA, ACTING AT BOTH GABA(A) AND GABA(B) RECEPTORS, INHIBITS THE RELEASE OF CHOLECYSTOKININ-LIKE MATERIAL FROM THE RAT SPINAL-CORD INVITRO
    BENOLIEL, JJ
    BOURGOIN, S
    MAUBORGNE, A
    POHL, M
    LEGRAND, JC
    HAMON, M
    CESSELIN, F
    [J]. BRAIN RESEARCH, 1992, 590 (1-2) : 255 - 262
  • [9] COMBINED DOSE-RATIO ANALYSIS OF CHOLECYSTOKININ RECEPTOR ANTAGONISTS, DEVAZEPIDE, LORGLUMIDE AND LOXIGLUMIDE IN THE GUINEA-PIG GALL-BLADDER
    BISHOP, LA
    GERSKOWITCH, VP
    HULL, RAD
    SHANKLEY, NP
    BLACK, JW
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (01) : 61 - 66
  • [10] Cholecystokinin and panic disorder: Past and future clinical research strategies
    Bradwejn, J
    Koszycki, D
    [J]. SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2001, 61 : 19 - 27